You need to Turn on Javascript or upgrade your Flash Player!

To Fully experience the Rich Media Solutions of this website, you must make sure that JavaScript is enabled.
You may also need to upgrade your Flash Player.

You can upgrade your flash player by
Clicking Here »

Influenza (flu) vaccine, the best protection against seasonal
flu, is approved for annual use in people older than 6 months, including healthy people and those with chronic medical conditions.

Each year, the viruses in the vaccine are chosen based on international surveillance and scientists' estimations about which types and strains of viruses will circulate in a given year.

2012-2013 Seasonal Influenza Vaccines

 Mfgr Description Size/Indication
Injectable
GlaxoSmithKline
FluLaval

Prescribing Information

5 mL 10-dose vial
18 years of age and older


Fluarix

Prescribing Information

0.5 mL prefilled syringes, needleless
3 years of age and older

Merck/CSL
Afluria

Prescribing Information

5 mL 10-dose vial
5 years of age and older
(ACIP recommends 9 years of age and older)*

0.5 mL prefilled syringes, needleless, 10 per box
(no preservatives)
5 years of age and older
(ACIP recommends 9 years of age and older)*

Novartis Vaccines Fluvirin

Prescribing Information

5 mL 10-dose vial
4 years of age and older

0.5 mL prefilled syringes, needleless, 10 per box
4 years of age and older

sanofi pasteur Fluzone

Prescribing Information

5 mL 10-dose vial
6 months of age and older

0.5 mL prefilled syringes, needleless, 10 per box
(no preservatives)
36 months of age and older

0.5 mL single-dose vials, 10 per box
(no preservatives)
36 months of age and older

0.25 mL prefilled syringes, needleless, 10 per box
(no preservatives)
6-35 months of age

  High-Dose

0.5 mL prefilled syringe,
(no preservatives)
65 years of age and older

  Intradermal

0.1 mL prefilled microinjection system, 10 per box
(no preservatives)
18 through 64 years of age

Intranasal Spray
MedImmune FluMist

Prescribing Information

0.2 mL prefilled, single-use intranasal spray
2-49 years of age

* Based on ACIP recommendations for the use of Afluria


Influenza Antiviral Treatment

 Mfgr Description  
Roche
Tamiflu
Prescribing Information

Vaccine Distributor FFF